Amlodipine Onset of Action
Amlodipine has a gradual onset of action that occurs over several hours, not minutes—blood pressure reductions are typically measured at 24 hours post-dose, making it unsuitable for acute blood pressure management.
Key Pharmacokinetic Characteristics
The FDA drug label explicitly states that amlodipine has a "gradual onset of action" and notes that "acute hypotension is unlikely" precisely because of this slow onset 1. This is a critical distinguishing feature from other antihypertensive agents used in acute settings.
Clinical Evidence on Timing
The clinical trials demonstrating amlodipine's efficacy measured blood pressure reductions at 24 hours post-dose, not in minutes 1. Studies showed:
- Blood pressure reductions averaging 12/6 mmHg (standing) and 13/7 mmHg (supine) were measured at the 24-hour mark
- The drug maintains blood pressure effect over the entire 24-hour dosing interval with little difference between peak and trough effect
- This sustained action is due to amlodipine's long half-life of 35-50 hours 2
Comparison to Acute Antihypertensive Agents
For context, the ACC/AHA guidelines describe truly rapid-acting IV antihypertensives used in hypertensive emergencies 3:
- Hydralazine: onset within 10-30 minutes
- Enalaprilat: onset around 15 minutes
- Nicardipine, clevidipine: immediate IV titration possible
Amlodipine is fundamentally different—it is designed for chronic blood pressure management, not acute control.
Clinical Implications
- Do not use amlodipine when rapid blood pressure reduction is needed (hypertensive emergencies, acute settings)
- The gradual onset is actually advantageous for chronic management: it provides smooth 24-hour control and maintains protection even with missed doses due to the long half-life 2
- Patients should be counseled that blood pressure lowering occurs gradually over hours to days, not immediately after taking the medication
Important Caveat
While animal studies suggest some vascular effects begin within 10-40 minutes in isolated vessels 4, this does not translate to clinically meaningful blood pressure reduction in humans within that timeframe. The clinical endpoint that matters—actual blood pressure lowering in patients—takes hours, not minutes.